Prior to Novartis, Mark worked at Pharmaceutical Formulations, Warner- Lambert Company and Block Drug. Mark has a BS in Chemistry from Fairleigh Dickinson University and is a named inventor on 12 patents ranging from diagnostic tests to controlled release systems.
The hiring of a CEO from the pharmaceutical community was planned at the Company's inception as was the separation of MonoSol Rx as a stand-alone business from MonoSol LLC. The original CEO of MonoSol Rx, P. Scott Bening, will continue as President & CEO of MonoSol LLC, a dynamic and growing business which is the world's largest manufacturer of Water Soluble Specialty films.
Mark Schobel commented: "MonoSol Rx has a vital IP portfolio and deep competencies in oral film delivery. I am looking forward to working with the Company's existing customers as well as helping to build new relationships."
Richard C. Fuisz M.D., a board member and the founder of Fuisz Technologies and Kosmos Pharma, commented: "I have known Mark for several years and he is an extremely bright and accomplished individual. As the Company continues its rapid growth, it has a firm hand at the tiller."
About MonoSol Rx LLC (http://www.monosolrx.com). MonoSol Rx LLC's manufacturing facility is located in Portage, Indiana. MonoSol Rx is a leading drug delivery company that uses film as a fast-dissolve oral drug delivery platform. MonoSol Rx previously acquired substantially all of the assets of Kosmos Pharma, including its extensive oral film intellectual property portfolio. MonoSol Rx's FDTAB® film oral dosage form looks like a postage stamp and dissolves readily on the tongue to deliver drugs to a patient, replacing the use of conventional tablets and capsules. MonoSol Rx
Source: MonoSol Rx LLC
